retatrutide cardiovascular effects triple agonist gip glp-1 glucagon receptor Agonism Based Therapies for Obesity Inotropic effects of retatrutide in

The cliff at 65 is about to move That cliff is about to get smaller

Core Supplies for This Protocol The essentials for running any reconstituted injectable: cold storage, accurate syringes, alcohol prep pads, and metabolic tracking

Rotate injection sites to avoid this

India has over 77 million adults with diabetes as of 2025

These drugs hold the potential to help address what continues to be an increasing obesity problem in the US

Retatrutide refers to a peptide known as LY3437943, which acts on three receptors: the glucagon receptor (GCGR), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon-like peptide-1 receptor (GLP-1R)